Clinical management of psychostimulant withdrawal: review of the evidence.
Li MJ, Shoptaw SJ.
Addiction. 2023 Apr;118(4):750-762. doi: 10.1111/add.16093. Epub 2022 Dec 12.
Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review.
Kitanaka J, Kitanaka N, Takemura M.
Neurochem Res. 2008 Jan;33(1):204-19. doi: 10.1007/s11064-007-9409-7. Epub 2007 Jun 29.
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Tak YJ, Lee SY.
Curr Obes Rep. 2021 Mar;10(1):14-30. doi: 10.1007/s13679-020-00422-w. Epub 2021 Jan 6.
Treatment for amphetamine withdrawal.
Shoptaw SJ, Kao U, Heinzerling K, Ling W.
Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003021. doi: 10.1002/14651858.CD003021.pub2.
Understanding Stimulant Use and Use Disorders in a New Era.
Ciccarone D, Shoptaw S.
Med Clin North Am. 2022 Jan;106(1):81-97. doi: 10.1016/j.mcna.2021.08.010.
Understanding the Mechanisms of Action and Effects of Drugs of Abuse.
Ciucă Anghel DM, Nițescu GV, Tiron AT, Guțu CM, Baconi DL.
Molecules. 2023 Jun 24;28(13):4969. doi: 10.3390/molecules28134969.
Stimulant withdrawal.
Lago JA, Kosten TR.
Addiction. 1994 Nov;89(11):1477-81. doi: 10.1111/j.1360-0443.1994.tb03746.x.
Treatment for amphetamine withdrawal.
Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P.
Cochrane Database Syst Rev. 2001;(4):CD003021. doi: 10.1002/14651858.CD003021.
Gut-derived bacterial LPS attenuates incubation of methamphetamine craving via modulating microglia.
Yu Z, Chen W, Zhang L, Chen Y, Chen W, Meng S, Lu L, Han Y, Shi J.
Brain Behav Immun. 2023 Jul;111:101-115. doi: 10.1016/j.bbi.2023.03.027. Epub 2023 Mar 31.
Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.
Bray B, Scholl JL, Tu W, Watt MJ, Renner KJ, Forster GL.
Brain Res. 2016 Aug 1;1644:278-87. doi: 10.1016/j.brainres.2016.05.030. Epub 2016 May 18.
